Tomorrow Health, a home-based care technology company based in New York City, shuttered its home medical equipment supply company in late May. 

With 268 recalls, the second quarter of 2022 hit the record of the highest number of recalled medical devices since 2020, according to an industry report from Sedgwick. 

The Center for U.S. Policy is asking the FDA to deem Bamboo Health's pharmaceutical software NarxCare as a misbranded product. 

FDA officials are warning that medical device shortages could worsen now that the public health emergency has expired because with its end a requirement for medical device companies to notify the agency of shortages also ceased. 

Draeger Medical, or Dräger US, recalled more than half a million airway devices because of a manufacturing error that can lead to hypoxia and death, the FDA said May 24. 

New York-based Northwell Health is training healthcare professionals to identify and address forced labor in the medical supply chain.

Vanderbilt University Medical Center and medical devicemaker Philips teamed up to reduce the Nashville, Tenn.-based system's carbon footprint. 

In a new partnership, Minneapolis-based Allina Health recently chose Elmhurst, Ill.-based MedSpeed to transport physical materials including pharmaceuticals and specimens.

During the COVID-19 pandemic, suppliers in every industry — especially healthcare — experienced unparalleled supply chain challenges. These disruptions extended to surgical glove manufacturers and in some instances affected clinicians' trust in suppliers.

United Hospital Supply Corp. has been cited by the Occupational Safety and Health Administration for 17 serious violations, three willful violations and one other-than-serious violation.

Several breakdown areas in the pharmaceutical supply chain were brought to light by COVID-19, but looking ahead, three areas should be at the core of improvements, experts say: health equity, trust and communication, and public-private partnerships.  

Many people aspire to be leaders in their field, but only a few make it to the executive level.

Revivicor, the company behind a pig-to-human heart transplant in 2022, is building a research and development center in Christiansburg, Va., radio station WTOP reported May 15.

Free COVID-19 vaccinations will continue to be available for uninsured Americans with support from programs developed by vaccine-makers Pfizer and Moderna and the HHS, CNBC reported May 12.

The FDA has ended a ban prohibiting gay and bisexual men in monogamous relationships from donating blood.  

Premier, a group purchasing organization for U.S. hospitals and health systems, said it's "evaluating potential strategic alternatives" — meaning it could try to sell itself. 

Technology advances, labor and supply chain shortages and the continuing migration of surgical procedures to ambulatory surgery centers (ASCs) are increasing pressure on hospitals to make their operating rooms (ORs) even smarter and more efficient.

GE Healthcare has selected James Saccara, a top executive at Baxter International, to serve as vice president and CFO, effective June 1. 

The FDA issued a warning May 4 about more than 500,000 COVID-19 tests made by SD Biosensor and distributed by Roche Diagnostics because of "significant concerns of bacterial contamination."

While COVID-19 caused the largest disruption to supply chains across industries, officials at the FDA's Center for Devices and Radiological Health said some of the issues within the healthcare supply chain existed before the pandemic. Now, experts say, is the time to proactively correct issues into the future, the Regulatory Affairs Professionals Society reported May 2.